Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01747876
Title Study of Safety and Efficacy in Patients With Malignant Rhabdoid Tumors (MRT) and Neuroblastoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | GBR | FRA | DEU | AUS

Facility Status City State Zip Country Details
UCSF Medical Center Dept of Pediatic Oncology San Francisco California 94143 United States Details
Childrens Healthcare of Atlanta Dept of Oncology Atlanta Georgia 30342 United States Details
Dana Farber Cancer Institute SC-7 Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Dept of Onc New York New York 10017 United States Details
Cincinnati Children's Hospital Medical Center Dept of Oncology Cincinnati Ohio 45229-3039 United States Details
St Jude s Childrens Research Hospital Dept of Oncology Memphis Tennessee 38105-2794 United States Details
Novartis Investigative Site Perth Western Australia 6840 Australia Details
Novartis Investigative Site Lyon Cedex 69373 France Details
Novartis Investigative Site Paris 75231 France Details
Novartis Investigative Site Villejuif Cedex 94805 France Details
Novartis Investigative Site Koeln Nordrhein-Westfalen 50937 Germany Details
Novartis Investigative Site Augsburg 86156 Germany Details
Novartis Investigative Site Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field